Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nomination Committee for the Saab Annual General Meeting 2020

The members of the Nomination Committee for Saab have now been appointed based on the shareholder structure on 31 August 2019, in accordance with a resolution by the Saab Annual General Meeting.The Nomination Committee shall, according to the Nomination Committee process adopted by the Annual General Meeting, consist of one representative from each of the four shareholders or group of shareholders with the largest numbers of votes, who wish to appoint a representative. In addition, the Chairman of the Board of Directors shall also be a member of the Nomination Committee. Members of the

Transcendent Group AB (publ) intends to list on Nasdaq First North Premier Growth Market

NOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE NOT WOULD BE COMPATIBLE WITH APPLICABLE REGULATIONS. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. Transcendent Group AB (publ) ("Transcendent Group" or the "Company"), a fast-growing consulting company specializing in Governance, Risk and Compliance (“GRC”), today announces its intention to launch an initial public offering and

Hansa Biopharma confirms follow-up meeting with FDA

In line with previous guidance, Hansa Biopharma has scheduled a follow-up meeting with the U.S. Food and Drug Administration. The meeting will take place on November 20th, 2019.Lund, Sweden September 25, 2019. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced that a date for a follow- up meeting with the U.S. Food and Drug Administration (FDA) has now been confirmed. The meeting will take place on November 20th, 2019. At the upcoming meeting with the FDA, Hansa Biopharma intends to continue the discussion from December 2018

Publishing of Outotec's January-September Interim Report 2019

OUTOTEC OYJ  PRESS RELEASE  SEPTEMBER 25, 2019 AT 9:00 AM Publishing of Outotec's January-September Interim Report 2019 Outotec’s January-September Interim Report 2019 will be published on Friday, October 25, approximately at 9:00 AM Finnish time. A teleconference hosted by President and CEO Markku Teräsvasara will be held on the same day at 2:00 PM. CFO Jari Ålgars will also be attending. PIN: 69630041# Finland: +358 981 710 310Sweden: +46 856 642 651 United Kingdom: +44 333 300 08 04 United States: +1 855 857 06 86  To register as a participant for the

Tenants now starting to move into 252 cooperative apartments at West Side Solna

Today, tenants will begin taking possession of their apartments in SSM’s West Side Solna, a project with 252 cooperative apartments. West Side Solna is a joint venture between SSM and Alecta that is expected to be fully completed by the end of Q1 2020. At the moment, 70 percent of homebuyers in the project have signed grant agreements with the Brf West Side Solna housing association. The handover process that has now started will have a marginal effect on SSM in Q3 2019 and from Q1 2020, it will impact the company’s cash flow positively.As planned, tenants will begin moving into the 252

Instalco wins new contract at Malmö Hospital

The Instalco company, Rörläggaren will be engaged in work associated with the expansion of Malmö hospital area via a new contract won by the installation group that it belongs to. Rörläggaren will be responsible for extensive, high-tech heating & plumbing installations customized to the hospital environment and with an order value of SEK 270 million.The comprehensive work associated with the expansion of Malmö Hospital started in 2015 and it is part of Region Skåne’s major investment in healthcare for southern Sweden. More than 100,000 square metres will be added to the hospital in the form

Altia calculated the carbon footprint of Koskenkorva Vodka – packaging and barley cultivation carry the greatest impact

Altia has calculated the carbon footprint of Koskenkorva Vodka. The majority of carbon dioxide emissions during the life-cycle of Koskenkorva Vodka derive from the product’s packaging and from the cultivation of the barley used as an ingredient in the vodka.  The energy-efficient Koskenkorva distillery’s proportion of the carbon footprint is relatively small.The carbon footprint of Koskenkorva Vodka packaged in a glass bottle is 2.19 kg CO2e/litre, while that of Koskenkorva Vodka packaged in a PET plastic bottle is 1.60 kg CO2e/litre. If these emissions are put in proportion with the

HKScan’s financial reporting 2020

HKScan Corporation                              Stock exchange release 25 September 2019, at 8:35 (EET)HKScan Corporation will publish the following financial reports in 2020: - Financial statements release for 2019 on Thursday, 6 February 2020 - January–March 2020 interim report on Thursday, 7 May 2020 - Half year financial report 2020 on Thursday, 16 July 2020 - January–September 2020 interim report on Thursday, 5 November 2020 The Annual Report 2019 will be published as a web report during the week 12/2020 at the latest. All financial reports will be published in Finnish

The Board of Directors of HKScan Corporation decided on the acquisition of the Company's own shares

HKScan Corporation                       Stock Exchange Release 25.9.2019, 8:30 (EET)The Board of Directors of HKScan Corporation has in its meeting on 24 September 2019 decided to use the authorisation granted by the Annual General Meeting held on 11 April 2019 to acquire the Company's own shares. The Board of Directors has decided to initiate a fixed-term share buy-back programme for the purpose of acquiring series A shares in the Company in order to meet the potential rewards arising from the share-based incentive scheme for key employees. The share acquisitions will begin at the

Skanska builds new healthcare building in Malmö, Sweden, signs additional contracts for about SEK 4.2 billion

Skanska has signed additional contracts with Region Skåne in the project to build a new healthcare building in Malmö, Sweden. The contract for the now contracted and remaining stages is worth about SEK 4.2 billion, which will be included in the Swedish order bookings for the third quarter 2019.The building consists of two towers, 10 and 11 stories above ground, interconnected with culverts and connecting corridors. It will accommodate over 2,200 rooms and will be the workplace for more than 2,000 people. With the new building, the hospital area will increase with more than 100,000 square

Eastnine rents out in Vilnius CBD

Eastnine AB (publ) has signed agreements to lease totally approximately 2,700 square metres of office space in the 3Bures-1,2 property in Vilnius CBD. The total contract value amounts to EUR 2.8 million during the rental period.Among the tenants are Swedbank which has signed a long-term lease agreement of 2,050 square metres and Unilever, manufacturer and seller of consumer goods, which has signed a five-year lease agreement of 300 square metres. All tenants are expected to move in during the second half of 2019 or around year-end. "It feels very satisfying that demand for first-class

Kungsleden leases 5,300 sq.m to prominent companies at Finnslätten in Västerås

Kungsleden has signed several new leases for Finnslätten in Västerås. Battery manufacturer Northvolt expands its space by approximately 1,700 sq.m, the biotechnology company Scandinavian Gene Synthesis (SGS DNA) leases approximately 2,800 sq.m and IF Friskis&Svettis leases 800 sq.m with an option for an additional 300.Kungsleden cooperates with ABB, Västerås Municipality and other prominent companies at Finnslätten to develop the area and create an attractive environment with a wide range of services that can attract additional innovative businesses and talent as well as research and

Stora Enso appoints Annica Bresky as President and Chief Executive Officer

STORA ENSO OYJ INSIDER INFORMATION 25 September 2019 at 8.00 EESTStora Enso’s Board of Directors has appointed Annica Bresky, 44, as the new President and CEO of the company as of 1 December 2019. Until then, Stora Enso’s current CEO Karl-Henrik Sundström continues in his position. Bresky is currently Head of Stora Enso’s Consumer Board division.“We are very happy to welcome Annica Bresky into her new position. Annica brings extensive experience of our industry and has a solid business background. We consider her the most suitable person to continue developing Stora Enso’s strategy and

Improved mapping of Swedish genes

People – or more specifically just Swedes – are more like chimpanzees than previously known. This is indicated in a genetic mapping of one thousand Swedish individuals, where new DNA sequences that should be included in the reference genome have been identified. The study is published in the scientific journal Molecular Biology and Evolution.In so-called whole genome sequencing, surveys are made of the total genome of an individual. It is still relatively rare in healthcare today, but it occurs at an increasing rate, for example in order to make an accurate diagnosis in the case of a rare

Great interest in DrugLog® at Drug Diversion conference

The IHFDA is holding its annual conference in Orlando September 23-25. It is aimed at decision makers and leading pharmacists in the health care sector who work with Drug Diversion prevention programs. The need to control returned narcotics from the OR is increasing and both delegates and representatives from major multinational companies have shown great interest in DrugLog®.The International Health Facility Diversion Association (IHFDA) holds its annual conference in Orlando September 23-25 and attracts approximately 200 delegates from US hospitals. It is aimed at decision makers and

Update on funding

Global Scanning enters into a SEK 235,000,000 facility agreement with Scandinavian Credit FundOn 28 August 2019, it was announced that Global Scanning A/S ("Global Scanning" or the "Group") has received credit committee approval from a third-party lender for a bilateral loan, to be used to refinance the Group’s outstanding SEK 200,000,000 bonds and for general corporate purposes. Global Scanning now announces that a SEK 235,000,000 facility agreement has been entered into.    On 24 September 2019, Global Scanning entered into a facility agreement with Scandinavian Credit Fund relating

Major League Baseball Players Alumni Association Brings Swing with the Legends Golf Classic to Baltimore, MD

Event to feature 1983 Baltimore Orioles World Series champion teammates and other former MLB playersColorado Springs, Colo. – The Major League Baseball Players Alumni Association will host a Swing with the Legends celebrity golf tournament featuring former Orioles, All-Stars, World Series champions and other baseball alumni. The golf tournament will take place on Friday, September 27th, 2019 with proceeds benefitting the Cal Ripken Sr. Foundation  and the MLBPAA. Alumni players attending* the event include 1983 Baltimore Orioles World Series champion

Industry-leading UPM Raflatac RAFNXT+ sustainable paper label materials now available in the Americas

(UPM Raflatac, Las Vegas, NV, USA, September 24, 2019 at 21:00 EET) – The next generation for sustainable packaging is now available in the Americas with the introduction of the UPM Raflatac RAFNXT+ paper label range. Unveiled at Pack Expo Las Vegas 2019, these materials feature UPM Raflatac’s Forest Positive lifecycle approach, benefitting nature and the environment as a whole. New RAFNXT+ paper laminates are ideal for a wide range of applications, including food, home and personal care, retail, logistics, and home and office. Not only does the Forest Positive approach go beyond

Windevo AB initiates written procedure

Windevo AB initiates written procedures regarding its up to SEK 50,000,000 Subordinated Second Lien Secured Callable PIK Interest Bonds 2018/2023a restructuring of its senior secured bonds 2015/2019 and its Maximum SEK 62,000,000 Senior Secured Callable Fixed Rate Bonds 2018/2021Windevo AB (the “Company” or the “Issuer”) summons meetings among the bondholders by way of a procedure in writing (the “Written Procedures”) for its outstanding bonds ISIN: SE0011337120 up to SEK 50,000,000 Subordinated Second Lien Secured Callable PIK Interest Bonds 2018/2023 and ISIN: SE0011337146 and

Enersize Oyj carries out a partially guaranteed rights issue of approximately 47 MSEK and publishes prospectus

The Board of Directors in Enersize Oyj (”Enersize” or the ”Company”) has today, following authorization given by the Extraordinary General Meeting, resolved on an issue of shares and warrants with preferential rights for the Company's existing shareholders (the "Rights Issue") announced 3 September 2019. The offering consists of a maximum of 72,403,016 new shares and a maximum of 36,201,508 warrants.Summary · The Rights Issue may, upon full subscription, provide Enersize with up to approximately 47 MSEK, before transaction costs related to the issue. Upon full subscription and full

Communication from Enersize Oyj's Extraordinary General Meeting

Today, September 24, 2019, an Extraordinary General Meeting was held in Enersize Oyj. Below is a summary of the decisions that were made. All decisions were taken unanimously.Resolution at Enersize Oyj's Extraordinary General Meeting Enersize Oyj's Extraordinary General Meeting was held on 24.9.2019 in Helsinki. A total of 3 shareholders, 12,141,675 shares and votes were represented at the Extraordinary General Meeting. The following issues were discussed at the General Meeting: Election of a new board member The General Meeting decided to elect a fifth Board member. Anders

Aripiprazol EQL Pharma approved

The pharmaceutical Aripiprazole EQL Pharma, oral solution 1mg / ml, has been approved by the Swedish Medicines Agency for sale.Aripiprazole EQL Pharma is a prescription drug used to treat schizophrenia in adults and adolescents from the age of 15 years. Aripiprazole EQL Pharma is also used to treat moderate to severe manic episodes in bipolar disorder. Aripiprazole EQL Pharma contains aripiprazole, a substance that has been registered as an oral solution in Sweden since 2005. The market for aripiprazole oral solution is limited to approximately SEK 2 million in total annual sales in

EAB GROUP PLC: ACQUISITION OF OWN SHARES 24.09.2019

EAB GROUP PLC  NOTIFICATION 24.09.2019 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 24.09.2019 Date 24.09.2019Exchange transaction BuyShare class EABAmount 110 Average price/share 2.8200 EUR  Highest price/share 2.8200 EUR Lowest price/share 2.8200 EUR Total price  310.20 EUR  The shares held by EAB Group Plc on 24.09.2019: EAB 1,135 On behalf of EAB Group Plc Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

There are no items matching the current filter
There are no more items matching the current filter
Back to top